HLI:NYSEHoulihan Lokey, Inc. Analysis
Data as of 2026-08-18 - not real-time
$127.01
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Houlihan Lokey, Inc. is bearish at $127.01, with short-term averages lagging the long-term ones. The last 30 days have lost 8.7%. RSI sits at 44.1, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at $112.83 and resistance at $147.01.
On valuation the read is fair — earnings multiple of 21.3 versus a 16.9 sector average, above the peer group. Consensus targets land 20.9% above where the shares trade now. Revenue is contracting at 15.5% on a 16.1% profit margin. The 2.24% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 46.7%, a beta of 0.73 and a maximum drawdown of 41.0%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 1 out of 10.
On valuation the read is fair — earnings multiple of 21.3 versus a 16.9 sector average, above the peer group. Consensus targets land 20.9% above where the shares trade now. Revenue is contracting at 15.5% on a 16.1% profit margin. The 2.24% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 46.7%, a beta of 0.73 and a maximum drawdown of 41.0%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 1 out of 10.
Top Market Events
Shares of investment banking firm Houlihan Lokey NYSE:HLI fell 8.Investment banking firm Houlihan Lokey NYSE:HLI in Q2 CY2026, with sales falling 15.Ariel Investments, an investment management company, released its “Appreciation Fund” Q2 2026 investor letter.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 156.97
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 21.3 versus sector average of 16.9
- Trading below the 200-day average of 156.97
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 21.3 versus sector average of 16.9
- Analyst targets imply +20.9% versus the current price
- Profit margin of 16.1% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth-15.50%
Profit Margin16.08%
P/E Ratio21.3
ROE17.79%
ROA11.17%
Debt/Equity20.85
P/B Ratio3.9
Op. Cash Flow$500.1M
Industry P/E16.9
Technical Analysis
TrendBearish
RSI44.1
Support$112.83
Resistance$147.01
MA 20$131.05
MA 50$135.53
MA 200$156.97
MACDBearish
VolumeDecreasing
Fear & Greed Index93.14
Valuation
Fair Value$67.46
Target Price$153.50
Upside/Downside20.86%
GradeFair
TypeBlend
Dividend Yield2.24%
Risk Assessment
Beta0.73
Volatility46.66%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.